These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25749931)

  • 1. Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
    Maeda Y; Shinohara T; Nagatsu A; Futakawa N; Hamada T
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S242-8. PubMed ID: 25749931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
    Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases.
    Kawamura J; Yazawa T; Sumida K; Kida Y; Ogawa R; Tani M; Kawasoe J; Yamamoto M; Harada H; Yamamoto H; Zaima M
    World J Surg Oncol; 2016 Feb; 14():56. PubMed ID: 26911142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion chemotherapy followed by hepatic resection in colorectal cancer with initially unresectable liver-limited metastases.
    Galizia G; De Vita F; Lieto E; Zamboli A; Morgillo F; Castellano P; Mabilia A; Auricchio A; Renda A; Ciardiello F; Orditura M
    Oncol Rep; 2013 Dec; 30(6):2992-8. PubMed ID: 24126855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
    Ammori JB; Kemeny NE; Fong Y; Cercek A; Dematteo RP; Allen PJ; Kingham TP; Gonen M; Paty PB; Jarnagin WR; D'Angelica MI
    Ann Surg Oncol; 2013 Sep; 20(9):2901-7. PubMed ID: 23771246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases.
    Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Togo S
    Ann Surg Oncol; 2007 Apr; 14(4):1336-46. PubMed ID: 17235718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
    Cummings LC; Payes JD; Cooper GS
    Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases.
    Fujimoto Y; Akasu T; Yamamoto S; Fujita S; Moriya Y
    J Gastrointest Surg; 2009 Sep; 13(9):1643-50. PubMed ID: 19582514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases.
    Okuno M; Hatano E; Kasai Y; Nishio T; Seo S; Taura K; Yasuchika K; Nitta T; Mori A; Okajima H; Kaido T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    Surg Today; 2016 Jun; 46(6):721-8. PubMed ID: 26315324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
    Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
    Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is hepatic resection for multiple liver metastases from colorectal carcinoma acceptable treatment?
    Tanaka K; Shimada H; Togo S; Ota M; Yamagichi S; Ike H
    Hepatogastroenterology; 2001; 48(39):803-7. PubMed ID: 11462928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
    Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer.
    Yamada H; Katoh H; Kondo S; Okushiba S; Morikawa T
    Hepatogastroenterology; 2001; 48(39):828-30. PubMed ID: 11462933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).
    Uetake H; Yasuno M; Ishiguro M; Kameoka S; Shimada Y; Takahashi K; Watanabe T; Muro K; Baba H; Yamamoto J; Mizunuma N; Tamagawa H; Mochizuki I; Kinugasa Y; Kikuchi T; Sugihara K
    Ann Surg Oncol; 2015 Mar; 22(3):908-15. PubMed ID: 25465375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatectomy for liver metastases in non-colorectal, non-neuroendocrine cancer patients. The survival benefit in primary unresectable cases.
    Maeda Y; Shinohara T; Katayama T; Futakawa N; Hamada T
    Int J Surg; 2015 Oct; 22():136-42. PubMed ID: 26277530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.